Ketone production in children with type 1 diabetes, ages 4–14 years, with and without nocturnal insulin pump suspension

Pediatric Diabetes

Volumn 18, Issue 6, 2017, Pages 422-427

  Wadwa, R Paul ^a   Chase, H Peter ^a   Raghinaru, Dan ^b   Buckingham, Bruce A ^c   Hramiak, Irene ^d   Maahs, David M ^a   Messer, Laurel ^a   Ly, Trang ^c   Aye, Tandy ^c   Clinton, Paula ^c   Kollman, Craig ^b   Beck, Roy W ^b   Lum, John ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

insulin pump; ketosis; pediatric; type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN; KETONE; ANTIDIABETIC AGENT;

ADOLESCENT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD KETONE LEVEL; BLOOD LEVEL; CAUCASIAN; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; FREQUENCY ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN PUMP SUSPENSION SYSTEM; KETOACIDOSIS; KETOGENESIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP TIME; TREATMENT DURATION; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; INSULIN INFUSION; MULTICENTER STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; KETONES; MALE;

EID: 84992530505     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12410     Document Type: Article

References (19)

1. Attia N, Jones TW, Holcombe J, Tamborlane WV. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 1998: 21: 817–821.
2. Castillo MJ, Scheen AJ, Lefebvre PJ. The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose level. J Clin Endocrinol Metab 1996: 81: 1975–1978.
3. Guerci B, Benichou M, Floriot M et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003: 26: 1137–1141.
4. Krzentowski G, Scheen A, Castillo M, Luyckx AS, Lefebvre PJ. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia 1983: 24: 314–318.
5. Maahs DM, Calhoun P, Buckingham BA et al. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care 2014: 37: 1885–1891.
6. Orsini-Federici M, Akwe JA, Canonico V et al. Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated patients with type 1 diabetes. Diabetes Technol Ther 2006: 8: 67–75.
7. Pickup JC, Viberti GC, Bilous RW et al. Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia 1982: 22: 175–179.
8. Sherr JL, Collazo MP, Cengiz E et al. Safety of nighttime 2-hour suspension of basal insulin in pump-treated type 1 diabetes even in the absence of low glucose. Diabetes Care 2014; 37: 773–779
9. Tsalikian E, Kollman C, Tamborlane WV et al. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006: 29: 2200–2204.
10. Beck RW, Raghinaru D, Wadwa RP, Chase HP, Maahs DM, Buckingham BA. Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care 2014: 37: 1224–1229.
11. Bier DM, Leake RD, Haymond MW et al. Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 1977: 26: 1016–1023.
12. Langdon D, Stanley CA, Sperling MA. Hypoglycemia in the Infant and Child. 3rd edn. Philadelphia, PA: Saunders Elsevier, 2008.
13. Pagliara AS, Karl IE, De Vivo DC, Feigin RD, Kipnis DM. Hypoalaninemia: a concomitant of ketotic hypoglycemia. J Clin Invest 1972: 51: 1440–1449.
14. Samuelsson U, Ludvigsson J. When should determination of ketonemia be recommended? Diabetes Technol Ther 2002: 4: 645–650.
15. Buckingham BA, Raghinaru D, Cameron F et al. Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care 2015: 38: 1197–1204.
16. Wolfsdorf JI, Allgrove J, Craig ME et al. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes 2014: 15 (Suppl 20): 154–179.
17. Chaussain JL, Georges P, Calzada L, Job JC. Glycemic response to 24-hour fast in normal children: III. Influence of age. J Pediatr 1977: 91: 711–714.
18. Chase HP, Maahs DM. Understanding Diabetes. Denver, CO: American Web Publishing, 2015.
19. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv Data 2000;8:1–27.